Significant Ownership of Anson Funds Management LP

Signature - Title
/s/ Tony Moore - Tony Moore, Manager
Location
Dallas, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Anson Funds Management LP.

Follow Filing Activity

Follow Anson Funds Management LP and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of Anson Funds Management LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BLUW Blue Water Acquisition Corp. III Class A Ordinary Shares, $0.0001 par value 9.9% $26,677,200 2,585,000 Anson Funds Management LP 31 Dec 2025
CEPO CANTOR EQUITY PARTNERS I, INC. Class A ordinary shares, par value $0.0001 per share 9.9% $21,172,605 2,039,750 Anson Funds Management LP 08 Dec 2025
STSS Sharps Technology Inc. Common Stock, par value $0.0001 per share 9.9% $9,000,000 1,800,000 Anson Funds Management LP 31 Mar 2025
TOON Kartoon Studios, Inc. Common Stock, par value $0.001 per share 9.9% $4,739,015 6,581,965 Anson Funds Management LP 31 Dec 2025
ADD Color Star Technology Co., Ltd. Class A Ordinary Shares, par value $0.04 9.9% $3,947,363 5,639,090 Anson Funds Management LP 31 Mar 2025
XXII 22nd Century Group, Inc. Common Stock, $0.00001 par value 9.9% $625,834 763,212 Anson Funds Management LP 31 Dec 2025
DGLY DIGITAL ALLY, INC. Common Stock, $0.001 par value 9.9% $409,344 576,541 Anson Funds Management LP 31 Jan 2024
FCRSU FutureCrest Acquisition Corp. Equity Units 9.8% $25,970,000 2,450,000 Anson Funds Management LP 30 Sep 2025
TVA Texas Ventures Acquisition III Corp. Class A Ordinary Shares, par value $0.0001 per share 9.8% $23,561,379 2,199,942 Anson Funds Management LP 31 Dec 2025
NWAXU New America Acquisition I Corp. Units, each consisting of one share of Class A common stock, par value $0.0001 per share, and one-half of one redeemable warrant 8.6% $30,901,991 2,968,491 Anson Funds Management LP 31 Dec 2025
ZNB Zeta Network Group Class A Ordinary Shares, par value $0.0025 8.2% $20,366 +$20,366 185,146 Anson Funds Management LP 31 Mar 2026
IMPP Imperial Petroleum Inc. Common Stock, $0.01 par value per share 7.8% $14,872,057 -$3,831,309 3,466,680 -20% Anson Funds Management LP 31 Mar 2026
LOVE Lovesac Co Common Stock, par value $0.00001 per share 7.1% $21,906,682 +$2,375,814 1,045,665 +12% Anson Funds Management LP 10 Apr 2025
ONCY Oncolytics Biotech, Inc. Common Stock, no par value 7% $10,708,670 -$751,370 7,649,050 -6.6% Anson Funds Management LP 30 Sep 2025
SEVCF Sono Group N.V. Ordinary Shares 7% $9,979 99,787 Anson Funds Management LP 31 Mar 2026
KWM K Wave Media Ltd. Ordinary shares, no par value per share 6.1% $1,720,500 3,823,333 Anson Funds Management LP 31 Mar 2026
ASST Strive, Inc. Class A Common Stock, $0.001 par value 5.9% $37,107,450 -$329,375,797 3,703,708 -90% Anson Funds Management LP 31 Mar 2026
LAES SEALSQ Corp Ordinary Shares, par value USD 0.01 per share 5.6% $26,161,166 12,457,698 Anson Funds Management LP 31 Mar 2026
SLS SELLAS Life Sciences Group, Inc. Common Stock, par value $0.0001 per share 4.9% $31,046,889 +$6,010,196 7,481,178 +24% Anson Funds Management LP 31 Dec 2025
NA Nano Labs Ltd. Class A Ordinary Shares, par value $0.002 per share 4.9% $6,700,968 -$3,064,608 1,240,920 -31% Anson Funds Management LP 30 Sep 2025
REKR Rekor Systems, Inc. Common Stock, $0.0001 par value 4.9% $5,948,493 7,166,859 Anson Funds Management LP 31 Dec 2025
NRXP NRX Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 4.9% $3,855,556 +$292,512 1,736,737 +8.2% Anson Funds Management LP 31 Mar 2026
DVLT Datavault AI Inc. Common Stock, par value $0.0001 per share 4.9% $2,668,401 3,214,941 Anson Funds Management LP 31 Mar 2025
GWAV Greenwave Technology Solutions, Inc. Common Stock, $0.001 par value per share 4.9% $738,914 -$375,013 3,212,670 -34% Anson Funds Management LP 30 Jun 2025
OBLG OBLONG, INC. Common Stock, $0.0001 par value 4.9% $318,473 -$60,929 123,439 -16% Anson Funds Management LP 30 Sep 2025
SILO Silo Pharma, Inc. Common stock, par value $0.0001 per share 4.9% $265,805 -$96,100 699,486 -27% Anson Funds Management LP 31 Dec 2025
ELAB PMGC HOLDINGS INC. Common Stock, $0.0001 par value 4.9% $31,815 1,060,505 Anson Funds Management LP 31 Dec 2024
APDN Applied DNA Sciences, Inc. Common Stock, $0.001 par value 4.9% $11,307 -$84,302 67,828 -88% Anson Funds Management LP 30 Sep 2025
CETX CEMTREX, INC. Common Stock, $0.001 par value 4.9% $9,961 90,554 Anson Funds Management LP 31 Dec 2024
HEPA Hepion Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 4.9% 576,482 -3.2% Anson Funds Management LP 30 Jun 2025
XXII 22nd Century Group, Inc. Common Stock, $0.00001 par value 4.9% 602,654 +242% Anson Funds Management LP 30 Jun 2025
LM FUNDING AMERICA, INC. Common Stock, par value $0.001 4.9% 741,777 -47% Anson Funds Management LP 31 Dec 2025
MHUA MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO., LTD. Ordinary Shares, $0.0005 par value 4.8% $404,243 1,205,255 Anson Funds Management LP 31 Dec 2024
ATNF 180 Life Sciences Corp. Common Stock, $0.0001 par value 4.5% 245,750 +9.1% Anson Funds Management LP 31 Mar 2025
NNDM Nano Dimension Ltd. Ordinary Shares, NIS 5.00 par value 4.2% $14,673,882 -$11,831,639 9,057,952 -45% Anson Funds Management LP 11 Jul 2025
CYN Cyngn, Inc. Common Stock, $0.00001 par value 4.2% $65,939 -$1,819,725 77,639 -97% Anson Funds Management LP 31 Mar 2025
MEIP MEI Pharma, Inc. Common Stock, $0.00000002 par value 3.7% 1,093,188 Anson Funds Management LP 22 Jul 2025
SPRO SPERO THERAPEUTICS, INC. Common Stock, par value $0.001 per share 2.9% $4,587,932 1,615,469 Anson Funds Management LP 30 Jun 2025
ENSC Ensysce Biosciences, Inc. Common Stock, $0.0001 par value 2.1% $209,957 411,681 Anson Funds Management LP 31 Dec 2024
BJDX BLUEJAY DIAGNOSTICS, INC. Common Stock, $0.0001 par value 1.4% $25,756 367,950 Anson Funds Management LP 31 Dec 2024
UPC UNIVERSE PHARMACEUTICALS, INC. Ordinary Shares, $0.01875 par value 1% 234,374 -70% Anson Funds Management LP 31 Mar 2025
BRR Procap Financial Inc. Common Stock, par value $0.001 per share 0.5% $730,678 -$12,608,001 408,200 -95% Anson Funds Management LP 31 Mar 2026
LGMK LOGICMARK, INC. Common Stock, $0.0001 par value 0.3% $20,542 128,385 Anson Funds Management LP 31 Dec 2024
CHSN Chanson International Holding Class A Ordinary Shares, par value $0.001 per share 0.3% $5,000 -$189,817 100,000 -97% Anson Funds Management LP 30 Sep 2025
MBAV M3-BRIGADE ACQUISITION V CORP. Class A ordinary shares, par value $0.0001 per share 0.2% $539,500 50,000 Anson Funds Management LP 08 Dec 2025
RNAZ TRANSCODE THERAPEUTICS, INC. Common Stock, $0.0001 par value 0.1% $9,494 -$30,224 27,125 -76% Anson Funds Management LP 30 Jun 2025
DGLY DIGITAL ALLY, INC. Common Stock, $0.001 par value 0.03% $15,704 47,117 Anson Funds Management LP 30 Jun 2025
MCGA Yorkville Acquisition Corp. Class A Ordinary Shares, $0.0001 par value 0% $0 -$18,007,622 0 -100% Anson Funds Management LP 31 Mar 2026
SRM SRM ENTERTAINMENT, INC. Common Stock, $0.0001 par value 0% $0 -$558,094 0 -100% Anson Funds Management LP 31 Mar 2025
EMPD Empery Digital Inc. Common Stock, $0.00001 par value per share 0% $0 -$21,981,861 0 -100% Anson Funds Management LP 31 Mar 2026
BOXL Boxlight Corporation Class A Common Stock, par value $0.0001 0% $0 -$219,760 0 -100% Anson Funds Management LP 31 Dec 2025
CJET Digital Currency X Technology Inc. Class A Ordinary Shares, par value $0.003 per share 0% $0 -$63,053 0 -100% Anson Funds Management LP 31 Mar 2026
FMTO Femto Technologies Inc. Subordinate Voting Shares, without par value 0% $0 -$1,624,040 0 -100% Anson Funds Management LP 30 Jun 2025

Schedules 13D/G Reported by Anson Funds Management LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .